Basic Information

Common Name
B-hPD-L1 plus/hCD47 MC38
Aliases
CD274, PDCD1L1, IAP, MER6, OA3
Catalog Number
320714
Cell Type/Disease
Colon carcinoma
Species/Strain
Mus musculus, C57BL/6
NCBI Gene ID
Application
B-hPD-L1 plus/hCD47 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Description

The mouse Pdl1 gene and Cd47 gene were replaced by human PD-L1 and CD47 coding sequence in B-hPD-L1 plus/hCD47 MC38 cells. Human PD-L1 and CD47 are highly expressed on the surface of B-hPD-L1 plus/hCD47 MC38 cells.

Targeting strategy

  • The exogenous promoter and human PD-L1 coding sequence was inserted to replace part of murine exon 3. The insertion disrupts the endogenous murine Pdl1 gene, resulting in a non-functional transcript.
  • The exogenous promoter and human CD47 coding sequence was inserted to replace part of murine exon 2 and all of exon 3. The insertion disrupts the endogenous murine Cd47 gene, resulting in a non-functional transcript.

Protein expression analysis

PD-L1 and CD47 expression analysis in B-hPD-L1 plus/hCD47 MC38 cells by flow cytometry. Single cell suspensions from B-hPD-L1 plus/hCD47 MC38 cultures were stained with species-specific anti-PD-L1 and anti-CD47 antibodies. Human PD-L1 and CD47 were detected on the surface of B-hPD-L1 plus/hCD47 MC38 cells. The 3-D07 clone of B-hPD-L1 plus/hCD47 MC38 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes

Subcutaneous homograft tumor growth of B-hPD-L1 plus/hCD47 MC38 cells. B-hPD-L1 plus/hCD47 MC38 cells (5×105) were subcutaneously implanted into B-hPD-L1/hSIRPA/hCD47 mice (female, 8-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hPD-L1 plus/hCD47 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

Back to top